Evidence map›Paper›PMID 40438976›Full record

ArticleHaematologica2025

MATRix and HD-MTX/IFO/DEP treatment and autologous stem cell transplantation in secondary central nervous system lymphoma: a Dutch retrospective analysis.

Fleur A De Groot, Floriske G Stedema, Esther J Kret, Lorraine M De Haan, Patty M Jansen, Stefan Böhringer, Arjan Diepstra, Marjolein W M Van der Poel, Myrurgia Abdul Hamid, Liane C J Te Boome and 7 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Haematologica, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Fleur A De GrootDepartment of Hematology, Leiden University Medical Center, Leiden.
Floriske G StedemaDepartment of Hematology, University of Groningen, University Medical Center Groningen, Groningen.
Esther J KretDepartment of Hematology, Leiden University Medical Center, Leiden.
Lorraine M De HaanDepartment of Pathology, Leiden University Medical Center, Leiden.
Patty M JansenDepartment of Pathology, Leiden University Medical Center, Leiden.
Stefan BöhringerDepartment of Biomedical Data Sciences and department of Pharmacology and Toxicology, Leiden University Medical Center, Leiden.
Arjan DiepstraDepartment of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, Groningen.
Marjolein W M Van der PoelDepartment of Internal Medicine, Division of Hematology, GROW School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht.
Myrurgia Abdul HamidDepartment of Pathology, Maastricht University Medical Center, Maastricht.
Liane C J Te BoomeDepartment of Hematology, Haaglanden Medical Center, Den Haag.
Valeska TerpstraDepartment of Pathology, Haaglanden Medical Center, Den Haag.
Mirian BrinkDepartment of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht.
Hendrik VeelkenDepartment of Hematology, Leiden University Medical Center, Leiden.
Ruben A L De GroenDepartment of Hematology, Leiden University Medical Center, Leiden.
Tim J A DekkerDepartment of Hematology, Leiden University Medical Center, Leiden.
Marcel NijlandDepartment of Hematology, University of Groningen, University Medical Center Groningen, Groningen.
Joost S P VermaatDepartment of Hematology, Leiden University Medical Center, Leiden. j.s.p.vermaat@lumc.nl.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40438976
PMCPMC12580713

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.